New

Hormone Replacement Therapy (HRT) Market

2021

Hormone Replacement Therapy (HRT) Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, Other Hormone Replacement Therapy); Route Of Administration (Oral, Parenteral, Transdermal); Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Others) and Geography

| Report Code: TIPRE00003836 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Hormone Replacement Therapy (HRT) Market 2028 By Product Replacement Therapy, Route Of Administration, Type of Disease and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Hormone replacement therapy (HRT) is the use of hormones to replace natural hormones when the body does not make them enough. For instance, hormone replacement therapy may be given to thyroid patients , menopause patients, several cancer patients, growth hormone deficiency patients etc. Furthermore, HRT was often administered to menopausal women for the relief of symptoms such as hot flushes, night sweats, sleep disturbances, psychological and genito-urinary disorders (urinary frequency and vaginal dryness), as well as the prevention of osteoporosis.

MARKET SCOPE



The "Global Hormone Replacement Therapy (HRT) Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the hormone replacement therapy (HRT) market with detailed market segmentation by product, route of administration and type of disease. The report provides key statistics on the market status of the leading hormone replacement therapy (HRT) market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on product the market is segmented as, estrogen replacement therapy, human growth hormone (HGH) replacement therapy, thyroid replacement therapy, testosterone replacement therapy, other hormone replacement therapy.
  • Based on route of administration the market is segmented as, oral, parenteral and transdermal.
  • Based on type of disease the market is segmented as, menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, others.

MARKET DYNAMICS


Drivers:



  • Increasing prevalence of hormonal imbalance disorders and menopausal disorders.
  • Advancements in hormone replacement therapies and growing R&D activities to develop more precise hormone replacement therapies.
  • New product launches and higher demand for hormone replacement therapies to treat conditions like cancers, sexual disorders, growth related disorders.

Restraints:



  • However, high cost of hormone replacement therapy is likely to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The hormone replacement therapy (HRT) market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the hormone replacement therapy (HRT) market in these regions.

IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY (HRT) MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities. The hormone replacement therapy market has been negatively impacted by the implementation of lockdown. In addition, the novel coronavirus exhibits a wide spectrum of clinical presentations, severity, and mortality rates. Furthermore, postmenopausal fertility treatment has been impacted by the pandemic, with research suggesting that dropping estrogen levels may put older women at greater risk of the disease, as well as the possibility that hormone withdrawal may accelerate COVID-19 progression.

MARKET PLAYERS



The report covers key developments in the hormone replacement therapy (HRT) market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from hormone replacement therapy (HRT) market are anticipated to lucrative growth opportunities in the future with the rising demand for hormone replacement therapy (HRT) in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the hormone replacement therapy (HRT) market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Pfizer Inc.
  • Abbott
  • Novo Nordisk
  • Novartis Pharmaceuticals Corporation.
  • Merck KGaA
  • Bayer AG
  • Lilly
  • Mylan N.V
  • Cyndea Pharma
  • Genentech, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hormone Replacement Therapy (HRT) Market - By Product
1.3.2 Hormone Replacement Therapy (HRT) Market - By Route Of Administration
1.3.3 Hormone Replacement Therapy (HRT) Market - By Type of Disease
1.3.4 Hormone Replacement Therapy (HRT) Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. HORMONE REPLACEMENT THERAPY (HRT) MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. HORMONE REPLACEMENT THERAPY (HRT) MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HORMONE REPLACEMENT THERAPY (HRT) MARKET - GLOBAL MARKET ANALYSIS
6.1. HORMONE REPLACEMENT THERAPY (HRT) - GLOBAL MARKET OVERVIEW
6.2. HORMONE REPLACEMENT THERAPY (HRT) - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. HORMONE REPLACEMENT THERAPY (HRT) MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ESTROGEN REPLACEMENT THERAPY
7.3.1. Overview
7.3.2. Estrogen Replacement Therapy Market Forecast and Analysis
7.4. HUMAN GROWTH HORMONE (HGH) REPLACEMENT THERAPY
7.4.1. Overview
7.4.2. Human Growth Hormone (HGH) Replacement Therapy Market Forecast and Analysis
7.5. THYROID REPLACEMENT THERAPY
7.5.1. Overview
7.5.2. Thyroid Replacement Therapy Market Forecast and Analysis
7.6. TESTOSTERONE REPLACEMENT THERAPY
7.6.1. Overview
7.6.2. Testosterone Replacement Therapy Market Forecast and Analysis
7.7. OTHER HORMONE REPLACEMENT THERAPY
7.7.1. Overview
7.7.2. Other Hormone Replacement Therapy Market Forecast and Analysis
8. HORMONE REPLACEMENT THERAPY (HRT) MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. TRANSDERMAL
8.5.1. Overview
8.5.2. Transdermal Market Forecast and Analysis
9. HORMONE REPLACEMENT THERAPY (HRT) MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF DISEASE
9.1. OVERVIEW
9.2. TYPE OF DISEASE MARKET FORECASTS AND ANALYSIS
9.3. MENOPAUSE
9.3.1. Overview
9.3.2. Menopause Market Forecast and Analysis
9.4. HYPOTHYROIDISM
9.4.1. Overview
9.4.2. Hypothyroidism Market Forecast and Analysis
9.5. MALE HYPOGONADISM
9.5.1. Overview
9.5.2. Male Hypogonadism Market Forecast and Analysis
9.6. GROWTH HORMONE DEFICIENCY
9.6.1. Overview
9.6.2. Growth Hormone Deficiency Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis

10. HORMONE REPLACEMENT THERAPY (HRT) MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hormone Replacement Therapy (HRT) Market Overview
10.1.2 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.1.3 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.1.4 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route Of Administration
10.1.5 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.1.6 North America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hormone Replacement Therapy (HRT) Market
10.1.6.1.1 United States Hormone Replacement Therapy (HRT) Market by Product
10.1.6.1.2 United States Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.1.6.1.3 United States Hormone Replacement Therapy (HRT) Market by Type of Disease
10.1.6.2 Canada Hormone Replacement Therapy (HRT) Market
10.1.6.2.1 Canada Hormone Replacement Therapy (HRT) Market by Product
10.1.6.2.2 Canada Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.1.6.2.3 Canada Hormone Replacement Therapy (HRT) Market by Type of Disease
10.1.6.3 Mexico Hormone Replacement Therapy (HRT) Market
10.1.6.3.1 Mexico Hormone Replacement Therapy (HRT) Market by Product
10.1.6.3.2 Mexico Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.1.6.3.3 Mexico Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2. EUROPE
10.2.1 Europe Hormone Replacement Therapy (HRT) Market Overview
10.2.2 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.2.3 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.2.4 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route Of Administration
10.2.5 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.2.6 Europe Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hormone Replacement Therapy (HRT) Market
10.2.6.1.1 Germany Hormone Replacement Therapy (HRT) Market by Product
10.2.6.1.2 Germany Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.2.6.1.3 Germany Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.2 France Hormone Replacement Therapy (HRT) Market
10.2.6.2.1 France Hormone Replacement Therapy (HRT) Market by Product
10.2.6.2.2 France Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.2.6.2.3 France Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.3 Italy Hormone Replacement Therapy (HRT) Market
10.2.6.3.1 Italy Hormone Replacement Therapy (HRT) Market by Product
10.2.6.3.2 Italy Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.2.6.3.3 Italy Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.4 Spain Hormone Replacement Therapy (HRT) Market
10.2.6.4.1 Spain Hormone Replacement Therapy (HRT) Market by Product
10.2.6.4.2 Spain Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.2.6.4.3 Spain Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.5 United Kingdom Hormone Replacement Therapy (HRT) Market
10.2.6.5.1 United Kingdom Hormone Replacement Therapy (HRT) Market by Product
10.2.6.5.2 United Kingdom Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.2.6.5.3 United Kingdom Hormone Replacement Therapy (HRT) Market by Type of Disease
10.2.6.6 Rest of Europe Hormone Replacement Therapy (HRT) Market
10.2.6.6.1 Rest of Europe Hormone Replacement Therapy (HRT) Market by Product
10.2.6.6.2 Rest of Europe Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.2.6.6.3 Rest of Europe Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hormone Replacement Therapy (HRT) Market Overview
10.3.2 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.3.3 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route Of Administration
10.3.5 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.3.6 Asia-Pacific Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hormone Replacement Therapy (HRT) Market
10.3.6.1.1 Australia Hormone Replacement Therapy (HRT) Market by Product
10.3.6.1.2 Australia Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.3.6.1.3 Australia Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.2 China Hormone Replacement Therapy (HRT) Market
10.3.6.2.1 China Hormone Replacement Therapy (HRT) Market by Product
10.3.6.2.2 China Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.3.6.2.3 China Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.3 India Hormone Replacement Therapy (HRT) Market
10.3.6.3.1 India Hormone Replacement Therapy (HRT) Market by Product
10.3.6.3.2 India Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.3.6.3.3 India Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.4 Japan Hormone Replacement Therapy (HRT) Market
10.3.6.4.1 Japan Hormone Replacement Therapy (HRT) Market by Product
10.3.6.4.2 Japan Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.3.6.4.3 Japan Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.5 South Korea Hormone Replacement Therapy (HRT) Market
10.3.6.5.1 South Korea Hormone Replacement Therapy (HRT) Market by Product
10.3.6.5.2 South Korea Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.3.6.5.3 South Korea Hormone Replacement Therapy (HRT) Market by Type of Disease
10.3.6.6 Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Market
10.3.6.6.1 Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Market by Product
10.3.6.6.2 Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.3.6.6.3 Rest of Asia-Pacific Hormone Replacement Therapy (HRT) Market by Type of Disease
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hormone Replacement Therapy (HRT) Market Overview
10.4.2 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.4.3 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route Of Administration
10.4.5 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.4.6 Middle East and Africa Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hormone Replacement Therapy (HRT) Market
10.4.6.1.1 South Africa Hormone Replacement Therapy (HRT) Market by Product
10.4.6.1.2 South Africa Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.4.6.1.3 South Africa Hormone Replacement Therapy (HRT) Market by Type of Disease
10.4.6.2 Saudi Arabia Hormone Replacement Therapy (HRT) Market
10.4.6.2.1 Saudi Arabia Hormone Replacement Therapy (HRT) Market by Product
10.4.6.2.2 Saudi Arabia Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.4.6.2.3 Saudi Arabia Hormone Replacement Therapy (HRT) Market by Type of Disease
10.4.6.3 U.A.E Hormone Replacement Therapy (HRT) Market
10.4.6.3.1 U.A.E Hormone Replacement Therapy (HRT) Market by Product
10.4.6.3.2 U.A.E Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.4.6.3.3 U.A.E Hormone Replacement Therapy (HRT) Market by Type of Disease
10.4.6.4 Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Market
10.4.6.4.1 Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Market by Product
10.4.6.4.2 Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.4.6.4.3 Rest of Middle East and Africa Hormone Replacement Therapy (HRT) Market by Type of Disease
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hormone Replacement Therapy (HRT) Market Overview
10.5.2 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis
10.5.3 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Product
10.5.4 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Route Of Administration
10.5.5 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Type of Disease
10.5.6 South and Central America Hormone Replacement Therapy (HRT) Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hormone Replacement Therapy (HRT) Market
10.5.6.1.1 Brazil Hormone Replacement Therapy (HRT) Market by Product
10.5.6.1.2 Brazil Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.5.6.1.3 Brazil Hormone Replacement Therapy (HRT) Market by Type of Disease
10.5.6.2 Argentina Hormone Replacement Therapy (HRT) Market
10.5.6.2.1 Argentina Hormone Replacement Therapy (HRT) Market by Product
10.5.6.2.2 Argentina Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.5.6.2.3 Argentina Hormone Replacement Therapy (HRT) Market by Type of Disease
10.5.6.3 Rest of South and Central America Hormone Replacement Therapy (HRT) Market
10.5.6.3.1 Rest of South and Central America Hormone Replacement Therapy (HRT) Market by Product
10.5.6.3.2 Rest of South and Central America Hormone Replacement Therapy (HRT) Market by Route Of Administration
10.5.6.3.3 Rest of South and Central America Hormone Replacement Therapy (HRT) Market by Type of Disease

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. HORMONE REPLACEMENT THERAPY (HRT) MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVO NORDISK
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVARTIS PHARMACEUTICALS CORPORATION.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK KGAA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BAYER AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LILLY
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MYLAN N.V
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CYNDEA PHARMA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. GENENTECH, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
"
The List of Companies

- Pfizer Inc.
- Abbott
- Novo Nordisk
- Novartis Pharmaceuticals Corporation.
- Merck KGaA
- Bayer AG
- Lilly
- Mylan N.V
- Cyndea Pharma
- Hisamitsu Pharmaceutical Co.,Inc
- Cipla, Inc
- Abbvie, Inc
- Glenmark Pharmaceutical Inc., USA
- Sun Pharmaceuticals, Inc
TIPRE00003836
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.